当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析 - 现金流量表

睿智医药

(300149)

  

流通市值:45.61亿  总市值:47.82亿
流通股本:4.82亿   总股本:5.05亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金542,808,003.33266,772,898.371,110,410,556.03812,104,041.96
  收到的税费返还18,117,401.239,940,782.3131,033,017.7629,282,855.49
  收到其他与经营活动有关的现金7,722,044.076,560,715.8719,893,705.4523,662,504.02
  经营活动现金流入小计568,647,448.63283,274,396.551,161,337,279.24865,049,401.47
  购买商品、接受劳务支付的现金220,672,952.72106,691,183.08327,934,107.22309,756,724.28
  支付给职工以及为职工支付的现金286,399,348.3130,687,297.09525,807,801.35396,424,765.31
  支付的各项税费11,521,389.782,718,752.8617,391,764.7115,441,909.67
  支付其他与经营活动有关的现金10,084,828.031,896,299.2499,704,797.6423,190,832.09
  经营活动现金流出小计528,678,518.83241,993,532.27970,838,470.92744,814,231.35
  经营活动产生的现金流量净额39,968,929.841,280,864.28190,498,808.32120,235,170.12
二、投资活动产生的现金流量:
  收回投资收到的现金7,781,040.5060,000,00030,000
  取得投资收益收到的现金24,43223,186.58252,444.2824,395.52
  处置固定资产、无形资产和其他长期资产收回的现金净额19,9278,990179,097.7930,064,162.64
  收到的其他与投资活动有关的现金43,207,054.0517,683,010.6566,763,414.2749,282,542.92
  投资活动现金流入小计51,032,453.5517,715,187.23127,194,956.3479,401,101.08
  购建固定资产、无形资产和其他长期资产支付的现金35,705,240.4113,775,377.8462,469,661.4541,657,076.12
  投资支付的现金7,177,499.977,362,499.9721,650,00010,050,000
  支付其他与投资活动有关的现金17,403,891.648,528,300112,980,00082,180,000
  投资活动现金流出小计60,286,632.0229,666,177.81197,099,661.45133,887,076.12
  投资活动产生的现金流量净额-9,254,178.47-11,950,990.58-69,904,705.11-54,485,975.04
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,073,921.574,823,921.57--
  其中:子公司吸收少数股东投资收到的现金-4,823,921.57--
  取得借款收到的现金100,000100,00021,000,0005,000,000
  收到其他与筹资活动有关的现金40,000,000-66,300,00035,300,000
  筹资活动现金流入小计45,173,921.574,923,921.5787,300,00040,300,000
  偿还债务支付的现金4,140,000505,152.2147,531,700.1414,260,000
  分配股利、利润或偿付利息支付的现金1,018,434.69-2,901,138.181,335,912.18
  支付其他与筹资活动有关的现金70,831,703.615,979,594.18116,578,402.9689,756,965.79
  筹资活动现金流出小计75,990,138.36,484,746.39167,011,241.28105,352,877.97
  筹资活动产生的现金流量净额-30,816,216.73-1,560,824.82-79,711,241.28-65,052,877.97
四、汇率变动对现金及现金等价物的影响-15,276,838.45-8,049,152.711,149,651.1-1,754,786.44
五、现金及现金等价物净增加额-15,378,303.8519,719,896.1742,032,513.03-1,058,469.33
  加:期初现金及现金等价物余额405,481,384.83405,481,384.83363,448,871.8363,448,871.8
  期末现金及现金等价物余额390,103,080.98425,201,281405,481,384.83362,390,402.47
补充资料:
  净利润-30,424,418.22-13,553,054.33-
  资产减值准备2,060,674.49-18,634,175.29-
  固定资产和投资性房地产折旧28,897,212.71-48,932,383.98-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧28,897,212.71-48,932,383.98-
  无形资产摊销1,681,241.27-3,112,684.35-
  长期待摊费用摊销23,342,144.9-46,173,014.54-
  处置固定资产、无形资产和其他长期资产的损失-1,502.08-41,843.85-
  固定资产报废损失554,619.83-1,353,358.44-
  公允价值变动损失0---
  财务费用16,244,987.23-18,507,912.26-
  投资损失1,765,583.28--12,154,847.66-
  递延所得税-10,584,892.06--6,874,717.94-
  其中:递延所得税资产减少-10,363,438.51--7,294,942.77-
    递延所得税负债增加-221,453.55-420,224.83-
  存货的减少-3,691,800.35-5,917,066.66-
  经营性应收项目的减少-36,805,732.63--89,398,246.09-
  经营性应付项目的增加-23,824,437.37-23,387,041.61-
  其他--54,080,567.03-
  现金的期末余额390,103,080.98-405,481,384.83-
  减:现金的期初余额405,481,384.83-363,448,871.8-
  现金及现金等价物的净增加额-15,378,303.85-42,032,513.03-
公告日期2026-08-292026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑